Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)
Authors:
- Lauren M. KentLKLauren M. Kent
- Lucy J. C. SmythLSLucy J. C. Smyth
- Jonathan PlumbJPJonathan Plumb
- Chris L. ClaytonCCChris L. Clayton
- Steve M. FoxSFSteve M. Fox
- David W. RayDRDavid W. Ray
- Stuart N. FarrowSFStuart N. Farrow
- Dave SinghDSDave Singh
- 1 February 2009
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 328 (2) , 458-468
Abstract
P38 mitogen-activated protein kinase (MAPK) signaling is known to be increased in chronic obstructive pulmonary disease (COPD) macrophages. We have studied the effects of the p38 MAPK inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d]-pyrimidin-2-yl]amino}ethyl)guanidine (SB706504) and dexamethasone on COPD macrophage inflammatory gene expression and protein secretion. We also studied the effects of combined SB706504 and dexamethasone treatment. Lipopolysaccharide (LPS)-stimulated monocyte derived macrophages (MDMs) and alveolar macrophages (AMs) were cultured with dexamethasone and/or SB706504. MDMs were used for gene array and protein studies, whereas tumor necrosis factor (TNF) α protein production was measured from AMs. SB706504 caused transcriptional inhibition of a range of cytokines and chemokines in COPD MDMs. The use of SB706504 combined with dexamethasone caused greater suppression of gene expression (-8.90) compared with SB706504 alone (-2.04) or dexamethasone (-3.39). Twenty-three genes were insensitive to the effects of both drugs, including interleukin (IL)-1β, IL-18, and chemokine (CC motif) ligand (CCL) 5. In addition, the chromosome 4 chemokine cluster members, CXCL1, CXCL2, CXCL3, and CXCL8, were all glucocorticoid-resistant. SB706504 significantly inhibited LPS-stimulated TNFα production from COPD and smoker AMs, with near-maximal suppression caused by combination treatment with dexamethasone. We conclude that SB706504 targets a subset of inflammatory macrophage genes and when used with dexamethasone causes effective suppression of these genes. SB706504 and dexamethasone had no effect on the transcription of a subset of LPS-regulated genes, including IL-1β, IL-18, and CCL5, which are all known to be involved in the pathogenesis of COPD.Keywords
This publication has 36 references indexed in Scilit:
- Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte LineageThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Gene network and canonical pathway analysis in prostate cancer: a microarray studyExperimental & Molecular Medicine, 2008
- Increased activation of p38 MAPK in COPDEuropean Respiratory Journal, 2007
- Differential Gene Expression Patterns and Interaction Networks in BCR-ABL–Positive and –Negative Adult Acute Lymphoblastic LeukemiasJournal of Clinical Oncology, 2007
- Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophagesBritish Journal of Pharmacology, 2006
- Second-Generation Inhibitors Demonstrate the Involvement of p38 Mitogen-Activated Protein Kinase in Post-Transcriptional Modulation of Inflammatory Mediator Production in Human and Rodent AirwaysThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Combinatorial roles of nuclear receptors in inflammation and immunityNature Reviews Immunology, 2005
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- p38-dependent marking of inflammatory genes for increased NF-κB recruitmentNature Immunology, 2001
- Inhibition of LPL Expression in Human Monocyte–Derived Macrophages Is Dependent on LDL Oxidation StateArteriosclerosis, Thrombosis, and Vascular Biology, 1998